In summary, VK2 directly binds to HSD17B4, but does not affect the expression of HSD17B4, to inhibit the proliferation of HCC cells by inhibiting the activation of Akt and MEK/ERK signaling pathways. This evidence concerns the gene AKT1 and hepatocellular carcinoma.